← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

Funds Holding in Top 10 Value Capital Flow New & Closed Increased & Reduced Calls & Puts Put/Call Ratio

New

Increased

Maintained

Reduced

Closed

Funds Holding 2,343

Funds Holding Change +182

Funds Holding Growth +8%

Value $399B

Holding in Top 10 465

Top 10 Change -1

Top 10 Growth -0.2%

Value Growth +5%

New 281

Increased 868

Reduced 1,043

Closed 74

Capital Inflow $16B

Capital Outflow $19.3B

Net Capital Flow -$3.31B

Capital Flow Change +$4.6B

Calls $6.06B

Puts $6.98B

Net Calls -$918M

Put/Call Ratio 1.15